当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析

梅花生物

(600873)

  

流通市值:298.97亿  总市值:298.97亿
流通股本:28.53亿   总股本:28.53亿

梅花生物(600873)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润10.19亿元,每股收益0.36元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益1545146.23万元,未分配利润1138934.65万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产2429685.85万元,负债884539.61万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入6,268,563,075.4625,069,288,294.6218,680,785,476.0612,642,718,053.37
营业总成本5,214,885,039.0521,862,599,657.6216,648,960,494.811,156,817,653.82
营业利润1,206,030,880.483,491,284,796.472,273,666,876.021,682,737,532.63
利润总额1,202,262,709.833,349,460,691.132,341,949,383.521,717,290,802.15
净利润1,018,706,366.462,740,427,215.561,995,321,648.291,473,823,789.92
其他综合收益-78,900,353.95-60,692,608.9639,914,573.3-30,039,576.1
综合收益总额939,806,012.512,679,734,606.62,035,236,221.591,443,784,213.82
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计9,499,388,391.598,899,880,069.398,649,625,914.878,133,713,790.25
非流动资产合计14,797,470,081.9814,909,677,942.2714,885,244,557.5414,402,707,642.67
资产总计24,296,858,473.5723,809,558,011.6623,534,870,472.4122,536,421,432.92
流动负债合计6,991,289,327.797,438,989,489.187,268,914,553.776,576,949,716.51
非流动负债合计1,854,106,796.611,795,623,221.551,547,914,394.631,832,882,200.17
负债合计8,845,396,124.49,234,612,710.738,816,828,948.48,409,831,916.68
归属于母公司股东权益合计15,451,462,349.1714,574,945,300.9314,718,041,524.0114,126,589,516.24
股东权益合计15,451,462,349.1714,574,945,300.9314,718,041,524.0114,126,589,516.24
负债和股东权益合计24,296,858,473.5723,809,558,011.6623,534,870,472.4122,536,421,432.92
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计6,754,619,422.6828,306,256,369.4521,107,357,469.3714,022,935,125.39
经营活动现金流出小计6,301,352,351.9923,679,541,578.9817,021,645,545.6211,787,117,002.27
经营活动产生的现金流量净额453,267,070.694,626,714,790.474,085,711,923.752,235,818,123.12
投资活动现金流入小计31,726,103.26245,600,886.5938,687,12649,337,447.28
投资活动现金流出小计2,182,847,932.672,894,559,694.33,768,697,832.582,142,735,387.26
投资活动产生的现金流量净额-2,151,121,829.41-2,648,958,807.71-3,730,010,706.58-2,093,397,939.98
筹资活动现金流入小计1,624,172,167.726,686,830,180.65,202,360,482.53,792,243,948.47
筹资活动现金流出小计1,447,935,110.159,424,882,464.297,044,969,625.425,248,768,205.51
筹资活动产生的现金流量净额176,237,057.57-2,738,052,283.69-1,842,609,142.92-1,456,524,257.04
汇率变动对现金及现金等价物的影响22,189,675.61111,541,460.3471,035,361.9668,078,736.56
现金及现金等价物净增加额-1,499,428,025.54-648,754,840.59-1,415,872,563.79-1,246,025,337.34
期末现金及现金等价物余额2,632,431,576.724,131,859,602.143,364,741,878.943,534,589,105.39
最新报告期:2025-04-23
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
申万宏源周超,宋涛1.161.221.302025-04-23
中信建投卢昊,邓天泽1.141.281.402025-04-23
长江证券马太1.111.191.232025-04-23
招商证券周铮,曹承安1.091.251.372025-04-22
华西证券周莎1.101.181.292025-04-22
TOP↑